EPISODE · Apr 11, 2025 · 7 MIN
#003 NTLA (Ticker NTLA) Lawsuit Breakdown: What Investors Need To Know
from Bulls & Betrayal · host bullsandbetrayal
Was Intellia Misleading Investors? The NTLA-3001 Lawsuit Explained In this episode of Bulls & Betrayal, Anna and Nate break down the explosive class action lawsuit against Intellia Therapeutics. Investors allege the company hyped a failing gene-editing program—NTLA-3001—while hiding key industry shifts. If you’re into Wall Street drama, biotech trends, or protecting your portfolio, this one’s for you. Expect deep dives, sharp analysis, and a dash of outrage. Subscribe & follow us @BullsAndBetrayal. We’re not lawyers or accountants, so don’t take this as legal or financial advice.
Embed this episode
NOW PLAYING
#003 NTLA (Ticker NTLA) Lawsuit Breakdown: What Investors Need To Know
No transcript for this episode yet
Similar Episodes
No similar episodes found.